Mount Sinai Advances in XPRIZE Healthspan with $1M Milestone Award — Mount Sinai Health System, Inc.

Event summary

Mount Sinai's NYC-Vita clinical trial team received a $1M Milestone 2 award in the XPRIZE Healthspan competition.
The team is one of 10 finalists advancing to the finals of the $101M global competition focused on extending healthy aging.
The NYC-Vita trial evaluates lifestyle and pharmaceutical interventions to improve immune function and support healthier aging.
Mount Sinai's multidisciplinary research team includes experts in immunology, neuroscience, metabolism, imaging, and clinical investigation.

The big picture

Mount Sinai's advancement in the XPRIZE Healthspan competition underscores the growing emphasis on extending healthy life spans through innovative therapeutic approaches. The $101M global competition highlights the increasing investment in aging research, with Mount Sinai positioning itself as a leader in integrating biomedical research and clinical care to address age-related decline. The scale of the competition and the potential for significant scientific breakthroughs could redefine how we approach healthy aging.

What we're watching

Execution Risk: Whether Mount Sinai can sustain the pace of research and clinical testing to meet the competition's ambitious goals.
Funding Dynamics: The ability to secure additional collaborators and philanthropic support to expand the Healthspan Program.
Competitive Landscape: How Mount Sinai's approach compares to other finalists from the U.S., South Korea, Japan, and China in the race to solve aging.